These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Activator protein accelerates dihydropyrimidine dehydrogenase gene transcription in cancer cells. Ukon K; Tanimoto K; Shimokuni T; Noguchi T; Hiyama K; Tsujimoto H; Fukushima M; Toge T; Nishiyama M Cancer Res; 2005 Feb; 65(3):1055-62. PubMed ID: 15705907 [TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-kappaB in regulated expression. Kang NY; Kang SK; Lee YC; Choi HJ; Lee YS; Cho SY; Kim YS; Ko JH; Kim CH Glycobiology; 2006 May; 16(5):375-89. PubMed ID: 16481330 [TBL] [Abstract][Full Text] [Related]
25. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells. Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145 [TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors. Heegaard AM; Xie Z; Young MF; Nielsen KL J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625 [TBL] [Abstract][Full Text] [Related]
27. The classical and a non-classical pathways associated with NF-kappaB are involved in estrogen-mediated regulation of calbindin-D9k gene in rat pituitary cells. Lee GS; Choi KC; Han HJ; Jeung EB Mol Cell Endocrinol; 2007 Oct; 277(1-2):42-50. PubMed ID: 17825480 [TBL] [Abstract][Full Text] [Related]
28. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. Hantusch B; Kalt R; Krieger S; Puri C; Kerjaschki D BMC Mol Biol; 2007 Mar; 8():20. PubMed ID: 17343736 [TBL] [Abstract][Full Text] [Related]
29. Functional mapping of the promoter region of the GNB2L1 human gene coding for RACK1 scaffold protein. Del Vecchio I; Zuccotti A; Pisano F; Canneva F; Lenzken SC; Rousset F; Corsini E; Govoni S; Racchi M Gene; 2009 Feb; 430(1-2):17-29. PubMed ID: 19000751 [TBL] [Abstract][Full Text] [Related]
30. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11). Inoue S; Oishi M Gene; 2005 Mar; 348():123-34. PubMed ID: 15777718 [TBL] [Abstract][Full Text] [Related]
31. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2. Rao CN; Reddy P; Reeder DJ; Liu Y; Stack SM; Kisiel W; Woodley DT Biochem Biophys Res Commun; 2000 Oct; 276(3):1286-94. PubMed ID: 11027624 [TBL] [Abstract][Full Text] [Related]
32. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors. Magan N; Szremska AP; Isaacs RJ; Stowell KM Biochem J; 2003 Sep; 374(Pt 3):723-9. PubMed ID: 12769819 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro. Konduri SD; Tasiou A; Chandrasekar N; Rao JS Int J Oncol; 2001 Jan; 18(1):127-31. PubMed ID: 11115549 [TBL] [Abstract][Full Text] [Related]
34. Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line. Hubé F; Reverdiau P; Iochmann S; Cherpi-Antar C; Gruel Y Thromb Res; 2003 Feb; 109(4):207-15. PubMed ID: 12757776 [TBL] [Abstract][Full Text] [Related]
35. Critical role of the transcription factor AP-1 for the constitutive and interferon-induced expression of IFI 16. Clarke CJ; Apostolidis V; Hii LL; Gough DJ; Trapani JA; Johnstone RW J Cell Biochem; 2003 May; 89(1):80-93. PubMed ID: 12682910 [TBL] [Abstract][Full Text] [Related]
36. [Role of tissue factor pathway inhibitor-2 in ovarian tumor migration and invasion]. Zhong R; Huang RB; Song SJ Ai Zheng; 2003 Oct; 22(10):1038-41. PubMed ID: 14558946 [TBL] [Abstract][Full Text] [Related]
37. Demonstration of a tissue factor pathway inhibitor 2 messenger RNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas. Hubé F; Reverdiau P; Iochmann S; Trassard S; Thibault G; Gruel Y Biol Reprod; 2003 May; 68(5):1888-94. PubMed ID: 12606321 [TBL] [Abstract][Full Text] [Related]
38. A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas. Tasiou A; Konduri SD; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Obeyesekere M; Rao JS Int J Oncol; 2001 Sep; 19(3):591-7. PubMed ID: 11494041 [TBL] [Abstract][Full Text] [Related]
39. Expression of attractin and its differential enzyme activity in glioma cells. Malík R; Mares V; Kleibl Z; Pohlreich P; Vlasicová K; Sedo A Biochem Biophys Res Commun; 2001 Jun; 284(2):289-94. PubMed ID: 11394875 [TBL] [Abstract][Full Text] [Related]
40. Identification of a human TFPI-2 splice variant that is upregulated in human tumor tissues. Kempaiah P; Chand HS; Kisiel W Mol Cancer; 2007 Mar; 6():20. PubMed ID: 17352822 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]